Clinigen Group signs agreement to divest its UK compounding business for £7.75 million
LONDON, UK: Clinigen Group plc announced the disposal of its non-core UK Specials manufacturing and Aseptic compounding business to Target Healthcare Ltd for a total...
Synairgen and Clinigen sign agreement for treatment of hospitalised patients with COVID-19
SOUTHAMPTON: Synairgen plc and Clinigen Group have signed an agreement to launch a Managed Access Program for Synairgen’s inhaled formulation of interferon beta (IFN-beta), SNG001,...